The more rapid formation of subcutaneous tumors in the presence of FOXC2 was confirmed in four additional primary mouse ovarian cancer cell lines that contained different combinations of genetic alterations (Figure 3B). The gene discussed is FOXC2; the disease is ovarian carcinoma.